2-(2'-Di-tert-butylphosphine)biphenylpalladium(II) acetate, 97%, 250mg

1-Isopropyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine, 95.0%, 250mg

PROPARGYL-PEG3-T-BUTYL ESTER, 95.0%, 5g

(S)-1-(3-Fluoro-4-methylphenyl)ethanamine hydrochloride, 97.0%, 250mg

2-(2-Chlorophenyl)cyclohexan-1-one, 97%, 100mg

2-(2,5-Dimethyl-1H-pyrrol-1-yl)phenylamine, 5g

Aluminiumoxid, nano, ROTI®nanoMETIC min. 99,9 %, 40 nm, 100 g, Glasverpackung

trans-trans-Muconic acid, 97%, 1g

4-Bromo-3-hydroxyphenylboronic acid, 98+%, 500mg

1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea, 99+%, 100mg

[1,1'-Biphenyl]-4-carboximidamide hydrochloride, 95.0%, 5g

(5-phenyl-4H-1,2,4-triazol-3-yl)acetic acid dihydrate, 95.0%, 250mg

4,5,6,7-Tetrahydrofuro[2,3-c]pyridine hydrochloride, 98%, 250mg